Toxoplasmosis is a main parasitic disease and may cause significant damage to the developing fetus and is a life-threatening opportunistic infection in immunocompromised persons. There are definite drugs available for the treatment of T. gondii infections. These drugs regimen, however, can cause side effects, however the macrolide antibiotic spiramycin is also used as a drug against T. gondii. This study tried to study the effectiveness of spiramycin in the treatment of toxoplasmosis.
Effectiveness of spiramycin for treatment of experimental toxoplasmosis in rats by the Real-time NASBA method

